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Abstract Infected endothelial cells are found to be resistant to
apoptosis possibly mediated by p53 cytoplasmic sequestration.
We explored whether the immediate early 84 kDa protein (IE84)
of cytomegalovirus (CMV) is responsible for p53 cytoplasmic
sequestration. The endothelial cells were transfected with
plasmids containing IE1 and 2 coding regions which are known
to synthesize IE84 and 72 proteins. Our study found that p53
expression was significantly elevated in endothelial cells trans-
fected with IE1 and 2 plasmids. However, p53 was only found in
the nucleus rather than sequestered in the cytoplasm. We have
demonstrated that IE84 and 72 are not responsible for p53
dysfunction caused by CMV infection, rather they upregulate
p53 function and promote endothelial apoptosis. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Response to injury is one of the major hypotheses on the
origin of atherosclerosis, which is marked as endothelial dys-
function and followed by development of fatty streaks com-
posed of lipid laden macrophages, T cells and smooth muscle
cells [1,2]. Early lesions may progress into ¢brous plaques and
complicated plaques [3]. A common viral infection may be the
¢rst step in the complex process of the development of athe-
rosclerosis, a concept that is consistent with the response-to-
injury hypothesis [4]. Human cytomegalovirus (CMV), a
member of the herpesviruses, can infect human vascular en-
dothelial cells and induces changes relevant to atherogenesis
[5]. CMV infection increases expression of endothelial surface
adhesion molecules, which upregulate the recruitment of gran-
ulocytes [6^8]. CMV infection also changes endothelium from
anticoagulant to procoagulant status [8]. Recently, it has been
found that actively proliferating CMV increases resistance of
endothelial cells to apoptosis, which provides a period long
enough for CMV propagation and for the initiation of athe-
rosclerosis [9]. The mechanism of resistance to apoptosis was
suggested to be cytoplasmic sequestration of p53 [9]. How-
ever, the molecular mechanism responsible for such sequestra-
tion is still not clear.
p53, a short-lived protein, is maintained at low levels in an
inactivate state in unstressed cells [10,11]. In response to stim-
ulation by cellular stress, p53 transcription and expression are
enhanced. The p53 protein is transiently stabilized as a tet-
ramer and functions as a transcriptional factor in the nucleus,
where it induces the transcription of genes including
p21WAF1=CIP1, bax, and hdm2 (mdm2 in mouse) [12^14].
p21WAF1=CIP1 and bax mediate the anti-proliferative function
of p53 by blocking cell cycle progression and provoking apop-
tosis [13,15]. However, hdm2 encodes a cellular negative reg-
ulator of p53, which constantly transfers p53 dimers and
monomers that split from the tetramer in the nucleus to the
cytoplasm. It also targets p53 to the cytoplasmic proteasome
for degradation [16]. Studies have shown that the blocking of
hdm2 nuclear export can stabilize p53 in the nucleus, and the
increasing expression of hdm2 can sequester most of the p53
in the cytoplasm [17].
A number of immediate early (IE) proteins of CMV are
expressed following entry of the virus into cells. IE2 encoded
IE84 is one of the major CMV immediate early proteins and
appears to be a promiscuous transactivator of viral and cel-
lular gene expressions [18]. IE84 has been found to bind to the
C-terminus of p53 that has the tetramerization function [19].
It also has been found that actively proliferating CMV in-
creases hdm2 expression but not p21 in vivo, which in turn
sequesters p53 in the cytoplasm for degradation [20]. We hy-
pothesize that CMV immediate early protein IE84 could con-
tribute to p53 cytoplasm sequestration possibly by preventing
p53 from forming tetramers.
2. Materials and methods
2.1. Endothelial cells culture
Primary human umbilical vein endothelial cells (HUVEC) were iso-
lated as previously described [9] and were grown at 37‡C in a humidi-
¢ed 5% CO2/95% air atmosphere in M199 medium, containing 10%
fetal bovine serum, penicillin (100 U/ml), streptomycin (100 Wg/ml),
sodium pyruvate (1 mmol/l), L-glutamine (4 mmol/l), heparin (30 Wg/
ml) and supplemented with endothelial cell growth factor (100 Wg/ml).
Cells cultured up to three passages were used in the experiment.
2.2. Plasmids
Plasmids containing the CMV major IE promoter upstream of IE84
(IE2 plasmid, a kind gift from Y.S. Huang, University of North
California), and IE84 and 72 coding regions (IE1 and 2 plasmid, a
kind gift from Linda Burns, University of Minnesota) have been pre-
viously described and veri¢ed in synthesis of the appropriate IE pro-
teins. Control plasmid does not encode CMV immediate early pro-
teins.
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2.3. Transfection
Con£uent HUVEC in a 100 mm petri dish were harvested by 0.1%
trypsin. 10 ml full medium was added to inactivate trypsin. The sus-
pension was centrifuged at 300Ug for 2 min to collect the cells. The
supernatant was discarded and cells were resuspended in full culture
medium to obtain a cell density of 5U106 cells/ml. 400 Wl of the cell
suspension was transferred to a 4 mm Gap cuvette. The IE2 or IE2
and IE1 72 containing plasmid (50 Wl, 36 Wg/ml) was added in the
cuvette and mixed by aspiration. The cuvette was placed in an electro-
poration apparatus (Genetronics) with the setting of 400 V, 975 WF
capacitance, 24 6 resistance, 12.5 ms pulse length. After electropora-
tion, cells were transferred to a 6 well plate containing 1% gelatin
coated coverslips and incubated at 37‡C 5% CO2/95% air for 48 h
before ¢xing them.
2.4. Infection of HUVEC with CMV
The VHL strain of CMV was used in the study (a kind gift from
Dr. W.J. Waldman, Ohio State University). The virus was propagated
as previously described [21]. Titration of the stock CMV was deter-
mined by a rapid quantitation assay using an immuno£uorescent de-
tection method for CMV major IE viral protein. CMV was thawed at
37‡C and sonicated in a cold water bath for 10 min. After removing
the growth medium, the con£uent HUVEC were washed with Hanks’
balanced salt solution (HBSS). CMV suspended in HUVEC culture
medium inoculated HUVEC at a multiplicity of infection of 0.1
plaque forming units/cell.
2.5. Immuno£uorescent staining and confocal microscopy
HUVEC grown on coverslips were washed with phosphate bu¡ered
solution (PBS), ¢xed with 4% paraformaldehyde for 20 min at room
temperature and permeabilized with cold methanol for 20 min. The
non-speci¢c binding was blocked by 1% bovine serum albumin (BSA)
and incubated with mouse anti-CMV immediate early protein anti-
body (1:10 000, Chemicon, Temecula, CA), and rabbit anti-p53 anti-
body (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA) at 37‡C
for 1 h. After washing with PBS, FITC conjugated goat anti-mouse
IgG (1:100, Sigma-Aldrich) and TRITC conjugated goat anti-rabbit
IgG (1:100, Sigma-Aldrich) were added and incubated in the dark at
room temperature for 40 min. After washing three times with PBS, the
coverslips were mounted with £uorescent-G (Southern Biotech Assoc.,
Birmingham, AL) and put face down onto slides. The edges of the
coverslips were sealed with nail polish. The £uorescent image was
visualized with an MRC 2000 confocal imaging system.
2.6. Viability assay
Viability was measured by a neutral red inclusion assay [22]. After
serum starvation for 48 h, transfected and non-transfected HUVEC
grown in 48 well cell culture plates were washed with HBSS bu¡er to
remove serum, and serum free M199 was added to one-half of the
wells, whereas serum containing medium was added to the other half.
After 48 h incubation at 37‡C in 5% CO2/95% air, the wells were
washed with HBSS. The culture medium (0.5 ml) containing the ly-
sosomally accumulated vital dye neutral red (50 Wg/ml) was added to
each well for 2 h. The cells were washed with HBSS, and the dye
absorbed by viable cells was extracted with acidi¢ed ethanol (50:50
mixture of absolute ethanol and 1% acetic acid). The optical density
(OD) of the supernatant was measured at 540 nm. Viability was cal-
culated as the percentage of OD ratio of serum starved cells to non-
serum starved cells. In each experiment, four test wells per group were
used.
2.7. Apoptosis and co-localization with CMV infection
After 48 h serum starvation, HUVEC grown on coverslips were
washed with HBSS, ¢xed with 4% paraformaldehyde, and permeabi-
lized with cold methanol. The apoptotic cells were detected by TdT-
mediated dUTP nick end labeling (TUNEL), using the In Situ Death
Kit (Cat. #1684795, Roche Molecular Biochemicals, Germany). After
TUNEL staining, the cells were washed with PBS, and incubated in
1% BSA for 20 min to block non-speci¢c binding of antibody. Then
the cells were incubated with mouse anti-CMV immediate early pro-
tein antibody (1:10 000, Chemicon, Temecula, CA) for 1 h at 37‡C
before TRITC conjugated goat anti-mouse IgG (1:500, Sigma-Al-
drich, St. Louis, MO) was added onto cells and incubated for 0.5 h.
The cells were then washed with HBSS three times and the images
were visualized under confocal microscopy.
2.8. Statistics
Results are expressed as the mean þ S.E.M. and Student’s t-test was
applied using the Sigmastat program.
3. Results
3.1. E¡ects of IE on p53 expression and cytoplasm
sequestration
For the primary cultured HUVEC, transfection e⁄ciency is
often a problem and most methods can only obtain 1 or 2%
cells transfected. With the optimized electroporation method
in our lab, we were able to achieve 10% HUVEC transfection
(data not shown). HUVEC were ¢xed and double labeled for
CMV IE84 and p53 protein after 48 h transfection with IE2.
As shown in Fig. 1.1A^C, p53 expression could not be de-
tected in non-transfected HUVEC and HUVEC transfected
with control plasmids. However, p53 expression in the IE2
transfected HUVEC was signi¢cantly elevated (Fig. 1.1D^
F). Most p53 in transfected cells distributed in the nucleus
rather than in the cytoplasm.
To explore whether IE84 needs the cooperation of IE72 to
sequester p53 in the cytoplasm, HUVEC was transfected with
IE1 and 2 plasmids (Fig. 1.1G^I). p53 was also upregulated in
IE1 and 2 transfected HUVEC. Most of the p53 was still
localized in the nucleus in the transfected cells. These ¢ndings
indicate that immediate early gene encoded proteins elevated
p53 expression, but did not sequester p53 in cytoplasm.
We further con¢rmed the ¢ndings in CMV directly infected
endothelial cells. CMV genes were sequentially expressed fol-
lowing the infection to mammalian cells. Expression of CMV
genes is divided into immediate early, early, and late stages
according to the type of gene expressed. Only the immediate
early genes are expressed in the ¢rst 6 h after the initial in-
fection. The immediate early proteins function as transcrip-
tional factors, which are essential for the early and late genes.
Since we found that IE gene encoded proteins did not seques-
ter p53 in cytoplasm, we explored whether the same phenom-
ena could be seen in the CMV infected HUVEC. After 4 h
infection, we localized p53 in the CMV infected cells by dou-
ble immuno£uorescent staining as described in Section 2. As
shown in Fig. 1.1J^L, p53 expression was elevated in CMV
infected HUVEC, and most p53 distributed in the nucleus
rather than the cytoplasm.
3.2. E¡ects of IE on endothelial apoptosis
It is known CMV abrogates p53 dependent apoptosis in-
duced by serum starvation. To explore whether IE84 alone or
IE84 and IE72 could inactivate p53 function, serum starvation
for 48 h was applied to IE2 or IE1 and 2 transfected HUVEC
to induce p53 dependent apoptosis. Apoptotic cells were dem-
onstrated using the TUNEL assay. As shown as Fig. 1.2, most
serum starvation induced apoptosis co-localized with IE2
alone (Fig. 1.2a^c) or IE1 and 2 (Fig. 1.2d^f) transfected
HUVEC. IE2 alone and IE1 and 2 transfected HUVEC
were more likely to undergo p53 dependent apoptosis. This
implies that IE84 alone or IE84 with IE72 did not inactivate
the p53 function of inducing apoptosis. In contrast, p53 up-
regulated by IE84 made more endothelial cells undergo apop-
tosis.
However, for endothelial cells infected with intact CMV
virus, p53 started to be sequestered to the cytoplasm when
the infected cells were observed at 48 h post-infection (data
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not shown). During this late stage, CMV infected endothelial
cells were clearly more resistant to apoptosis than controls.
These endothelial cells were also serum starved for 48 h after
48 h infection with CMV. The apoptosis which was identi¢ed
with TUNEL co-localized with CMV infection that was iden-
ti¢ed with immuno£uorescent staining of IE. As shown in the
merged photo of Fig. 2, no CMV infected HUVEC co-local-
ized with apoptosis. In other words, CMV infection protected
HUVEC from serum starvation induced apoptosis, which is
consistent with a previous report [9].
We also measured the cell viability after 48 h serum starva-
tion. The viability assay was conducted three times in tripli-
cate. As shown in Fig. 3, IE84 alone and IE84 with IE72 did
not protect HUVEC from serum starvation induced apoptosis
(P6 0.05). Fewer IE2 or IE1 and 2 transfected cells were
viable compared to control plasmid transfected and non-
transfected cells. In contrast, more viable cells were found in
CMV infected endothelial cells than in controls.
4. Discussion
In exploring the mechanism of CMV induced resistance to
p53 dependent apoptosis, we have shown that IE84 alone or
IE84 and 72 upregulated p53 expression but were unable to
sequester it in the cytoplasm. The upregulation of p53 expres-
sion is consistent with the report by Muganda et al. [23]. This
result was also con¢rmed in CMV infected HUVEC. At the
immediate early stage of infection, p53 was upregulated but
still localized in the nucleus. At this stage, IE proteins have
made cells more likely to undergo apoptosis possibly mediated
by upregulated p53. Humans may bene¢t from this increased
p53 expression and apoptosis at the immediate early stage of
CMV infection by eliminating CMV infected cells. This in-
creased apoptosis was also demonstrated in both IE2 and
IE1 and 2 transfected endothelial cells, which had increased
p53 expression and were more likely to undergo apoptosis.
The IE1 and 2 transfection also tended to co-localize with
positive apoptosis as demonstrated by the TUNEL assay.
Although Fortunato et al. [24] suggested that CMV infec-
tion increased the p53 level by reducing p53 degradation, re-
ports by Muganda et al. [23] indicated that IE84 could in-
crease p53 transcription and expression. Our results are
consistent with an increased expression. p53 has to be trans-
ported to the proteasome in the cytoplasm for degradation.
However, in IE2 or IE1 and 2 transfection and the immediate
early stage of CMV infection, all the elevated p53 was local-
ized in the nucleus rather than the cytoplasm.
Although IE84 has the capacity to bind to the C-terminus
of p53 [25], which could potentially inhibit p53 tetrameriza-
tion, and thus p53 function, our experiments were unable to
demonstrate whether there was any e¡ect on p53 tetrameriza-
tion. Nevertheless, we have clearly shown that p53 function
Fig. 1. CMV IE2 alone or IE1 and 2 increased p53 expression in HUVEC but did not sequester p53 in the cytoplasm. HUVEC were trans-
fected with IE2 or IE1 and 2 plasmids which encode IE84 and IE72 and 84 proteins respectively. We co-localized p53 and IE84 or IE72 and
84 in transfected HUVEC with immuno£uorescence staining as described in Section 2. p53 expression was increased in IE2 or IE1 and 2 trans-
fected HUVEC compared to non-transfected HUVEC, and all p53 localized in nucleus (1.1A^I). At the immediate early stage of CMV infec-
tion, p53 expression was upregulated and localized in the nucleus of HUVEC. HUVEC were infected with VHL CMV for 4 h, in which only
CMV immediate early proteins were expressed. p53 was upregulated in CMV infected cells compared to non-infected cells, and all the p53 lo-
calized in the nucleus of HUVEC (J^L). Serum starvation induced apoptosis co-localized with IE2 and IE1 and 2 transfected cells. After 48 h
transfection with IE2, IE1 and 2, non-speci¢c plasmid, HUVEC were serum starved for 48 h. Most of the apoptotic cells co-localized with IE2
or IE1 and 2 transfection (1.2a^f, i).
Fig. 2. CMV infection protected HUVEC from serum starvation in-
duced apoptosis. After 48 h infection, HUVEC were serum starved
for 48 h. The CMV infection was identi¢ed with immuno£uorescent
staining of IE, and apoptosis was identi¢ed with TUNEL staining.
The same images were merged together to co-localize the apoptosis
and CMV infection. As shown in the merged photo, no CMV in-
fected HUVEC co-localized with apoptosis.
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was upregulated rather than inactivated in IE transfected cells.
This could imply either that IE84 did not bind to the C-ter-
minal of p53 and inhibit p53 tetramerization, or that tetrame-
rization was not essential for p53 function.
In conclusion, IE84 upregulated p53 expression but did not
sequester p53 in the cytoplasm to inactivate p53 function.
Endothelial cells transfected with IE plasmids or at the early
stage of CMV infection were more likely to undergo apopto-
sis, which may be a protective mechanism for humans to
eliminate CMV infected cells. It should be noted, however,
that more studies will be needed to directly link the nuclear
p53 accumulation induced by CMV immediate early proteins
to the accelerated endothelial apoptosis.
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Fig. 3. IE2 or IE1 and 2 plasmids transfected HUVEC were not re-
sistant to serum starvation induced apoptosis compared to control
cells. After 48 h transfection with IE2 or IE1 and 2, half of the
HUVEC were serum starved for 48 h. Half of the cells were main-
tained in normal medium as control. Half of the HUVEC cultured
in normal medium and HUVEC infected with CMV for 48 h were
also serum starved for 48 h. The viability of serum starved cells was
measured with the neutral red inclusion assay and calculated as per-
centage of OD ratio of serum starved test cells to non-serum
starved cells. The viability of IE2 alone or IE2 with IE1 transfected
cells was signi¢cantly lower than the control cells. The CMV in-
fected cells (48 h), however, had increased viability.
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